References
- Al-Mayahi M, Cian A, Kressmann B, et al. Associations of diabetes mellitus with orthopaedic infections. Infect Dis (Lond). 2016;48:70–73.
- Ertugrul BM, Oryasin E, Lipsky BA, et al. Virulence genes fliC, toxA and phzS are common among Pseudomonas aeruginosa isolates from diabetic foot infections. Infect Dis (Lond). 2018;50:273–279.
- Jafari SM, Casper DS, Restrepo C, et al. Periprosthetic joint infection: are patients with multiple prosthetic joints at risk?. J Arthroplasty. 2012;27:877–880.
- Zeller V, Kerroumi Y, Meyssonnier V, et al. Analysis of postoperative and hematogenous prosthetic joint-infection microbiological patterns in a large cohort. J Infect. 2018;76:328–334.
- Perez-Jorge C, Gomez-Barrena E, Horcajada J-P, et al. Drug treatments for prosthetic joint infections in the era of multidrug resistance. Expert Opin Pharmacother. 2016;17:1233–1246.
- Curran B, Jonas D, Grundmann H, et al. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004;42:5644–5649.
- Ellington MJ, Kistler J, Livermore DM, et al. Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J Antimicrob Chemother. 2006;59:321–322.
- Lee JY, Ko KS. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int J Antimicrob Agents. 2012;40:168–172.
- Wi YM, Ji-Young C, Ji-Young L, et al. Antimicrobial effects of β-lactams on imipenem-resistant ceftazidime-susceptible Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017;61:e00054–e00017.
- Lee JY, Peck KR, Ko KS. Selective advantages of two major clones of carbapenem-resistant Pseudomonas aeruginosa isolates (CC235 and CC641) from Korea: antimicrobial resistance, virulence and biofilmforming activity. J Med Microbiol. 2013;62:1015–1024.